%PDF-1.4
%
43 0 obj
<>
endobj
40 0 obj
<>
endobj
101 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-12-14T19:58:48Z
2024-03-28T15:52:19-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-28T15:52:19-07:00
application/pdf
Heather
2001-948.dec02
uuid:e9eb9902-1dd1-11b2-0a00-f209276d7200
uuid:e9eb9905-1dd1-11b2-0a00-b80000000000
endstream
endobj
29 0 obj
<>
endobj
30 0 obj
<>
endobj
44 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
9 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
12 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
20 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
119 0 obj
[123 0 R]
endobj
120 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
/CS0 cs 0 0 0 0 scn
/GS1 gs
427 777 130 -27 re
f*
/CS0 CS 0 0 0 1 SCN
54 54 m
558 54 l
S
BT
0 0 0 1 scn
/TT0 1 Tf
0.02499 Tw 8 0 0 8 420.3613 35.9844 Tm
(The Journal of Rheumatology 2002; 29:12)Tj
0 Tw -45.7952 -0.0313 Td
(2596)Tj
ET
0 0 0 0 scn
/GS0 gs
103.25 59.75 407.5 -10.83 re
f*
0.5 w
103.25 59.75 407.5 -10.83 re
S
BT
0 0 0 1 scn
/GS1 gs
/TT1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 74.4 714.5293 Tm
(recommendations from a task force of the Osteoarthritis Research)Tj
0 Tc 0 -1.25 TD
[(Society)64.9 (. Osteoarthritis Cartilage 1996;4:217-43.)]TJ
-1.675 -1.25 Td
[(2.)-875 (Dougados M, Gueguen )54.9 (A, Nguyen M, et al. Radiological )]TJ
-0.00011 Tc 1.675 -1.25 Td
(progression of hip osteoarthritis: definition, risk factors and )Tj
0 Tc T*
[(correlations with clinical status. )54.9 (Ann Rheum Dis 1996;55:356-62.)]TJ
-1.675 -1.25 Td
[(3.)-875 (Auleley GR, Giraudeau B, Dougados M, Ravaud P)110.8 (. Radiographic)]TJ
-0.00011 Tc 1.675 -1.25 Td
(assessment of hip osteoarthritis progression: impact of reading)Tj
0 Tc T*
[(procedures for longitudinal studies. )54.9 (Ann Rheum Dis 2000;59:422-7.)]TJ
-0.00011 Tc -1.675 -1.25 Td
[(4.)-875.1 (Lassere MND, van der Heijde D, Johnson KR, Boers M, Edmonds)]TJ
0 Tc 1.675 -1.25 Td
(J. Reliability of measures of disease activity and disease damage in)Tj
T*
[(rheumatoid arthritis: implications for smallest detectable dif)17.8 (ference,)]TJ
T*
[(minimal clinically important dif)17.8 (ference, and analysis of treatment)]TJ
T*
[(ef)17.8 (fects in randomized controlled trials. J Rheumatol 2001;)]TJ
0 Tw T*
(28:892-903.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(5.)-875.1 (Auleley GR, Duch\351 )54.8 (A, Drape JL, Dougados M, Ravaud P)110.7 (.)]TJ
0 Tc 1.675 -1.25 Td
(Measurement of joint space width in hip osteoarthritis: influence of)Tj
T*
(joint positioning and radiographic procedure. Rheumatology)Tj
0 Tw T*
(2001;40:414-9.)Tj
0.02499 Tw -1.675 -1.25 Td
[(6.)-875 (Buckland-W)39.8 (right JC. Quantitative radiography of osteoarthritis.)]TJ
1.675 -1.25 Td
(Ann Rheum Dis 1994;53:268-75.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(7.)-875.1 (Conrozier )17.7 (T)73.9 (, Jousseaume CA, Mathieu P)110.7 (,)-0.1 ( et al. Quantitative)]TJ
0 Tc 1.675 -1.25 Td
(measurement of joint space narrowing progression in hip)Tj
T*
(osteoarthritis: a longitudinal retrospective study of patients treated)Tj
T*
[(by total hip arthroplasty)64.9 (. Br J Rheumatol 1998;37:961-8.)]TJ
-1.675 -1.25 Td
[(8.)-875 (Sharp JT)74 (, Gardner JC, Bennett EM. Computer)19.8 (-based methods for)]TJ
1.675 -1.25 Td
(measuring joint space and estimating erosion volume in the finger)Tj
T*
[(and wrist joints of patients with rheumatoid arthritis. )54.9 (Arthritis)]TJ
T*
(Rheum 2000;43:1378-86.)Tj
31.325 33.75 Td
[(9.)-875 (Conrozier )17.7 (T)74 (, Lequesne M, Favret H, et al. Measurement of the )]TJ
1.675 -1.25 Td
[(radiological hip joint space width. )54.9 (An evaluation of various)]TJ
T*
(methods of measurement. Osteoarthritis Cartilage 2001;9:281-6.)Tj
-2.175 -1.25 Td
[(10.)-875 (Gunther KP)110.8 (, Sun )36.8 (Y)129.2 (. Reliability of radiographic assessment in hip)]TJ
2.175 -1.25 Td
(and knee osteoarthritis. Osteoarthritis Cartilage 1999;7:239-46.)Tj
-0.00011 Tc -2.1381 -1.25 Td
[(1)36.8 (1)-0.1 (.)-875.1 (Lassere MND, van der Heijde D, Johnson KR. Foundations of the)]TJ
0 Tc 2.1381 -1.25 Td
[(minimally clinically important dif)17.8 (ference for imaging. J Rheumatol)]TJ
0 Tw T*
(2001;28:890-1.)Tj
0.02499 Tw -2.175 -1.25 Td
[(12.)-875 (Bruynesteyn K, van der Heijde D, Boers M, et al. Minimal )]TJ
2.175 -1.25 Td
[(clinically important dif)17.8 (ference in radiological progression of joint)]TJ
T*
(damage over 1 year in rheumatoid arthritis: preliminary results of a)Tj
T*
(validation study with clinical experts. J Rheumatol 2001;28:904-10.)Tj
-2.175 -1.25 Td
[(13.)-875 (Maillefert JF)79.8 (, Gueguen )54.8 (A, Nguyen M, et al. Evaluation of the)]TJ
2.175 -1.25 Td
(minimum clinically important change in radiological progression in)Tj
T*
(patients with hip osteoarthritis. Part I: validation using predictive)Tj
T*
[(validity for total hip arthroplasty)64.9 (. Rheumatology 2002;41:142-7.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(14.)-875.1 (Lassere MND, van der Heijde D, Johnson K, et al. Robustness and)]TJ
0 Tc 2.175 -1.25 Td
[(generalizability of smallest detectable dif)17.8 (ference in radiological)]TJ
T*
[(progression. J Rheumatol 2001;28:91)36.9 (1-3.)]TJ
-2.175 -1.25 Td
[(15.)-875 (Ravaud P)110.8 (, Giraudeau B, )54.9 (Auleley GR, et al. Radiographic )]TJ
2.175 -1.25 Td
(assessment of knee osteoarthritis: reproducibility and sensitivity to)Tj
T*
(change. J Rheumatol 1996;23:1756-64.)Tj
ET
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_0 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2002. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_1 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
90 0 obj
<>
endobj
106 0 obj
<>
endobj
46 0 obj
<>
endobj
52 0 obj
<>
endobj
51 0 obj
<>
endobj
83 0 obj
<>stream
HtV
PT}owY@Dp7OV(Z
NjvÏ+q+DubMIU[ͤƄ%F8v'j[u1VS}cLߙo=s=v! hZ:#kDpoy1PWFH<,H%
nڧ~^N O[>աKrn/iv 6ÑO{2@zw@n{"չ+Wu75^UНQ"IۆuE܈j-G-[dtl>` qO!*
i)|o hFD`8\3|PGb^:b-o
_Q65vokn`$ѣ+x# 4ƬEȔ
V
yve*D? ~C,Z\YM&bzm01H;uj1rfVs-@ղx<;{sU Nᖘ!fkcFXϮPg#d;~3+<5]䊙^,.Ef~Jbf [76W;';ZoͧOs,V[-'z%рx?bq''VDHd\BC#NkZt;KBGS5k:c}%\}:FxXLT~ޞЂwu".[DE*%\BgWR9gMr<+;d-EKײVmʱǻ]/G+U%ѕcV:``6^ft"&i(
`f5K#fVGqg_p3m!.F|Q<$JD("$jEX%֊bh%8'.Cd4%٤a9_FFE6
ZVHvB.hWodA_/_:3I%νC]o. {kz2U~~7Gr"oQ{٩}ҧ$)ԍߓCOx=RS>< )߫gq.Cפ@F(z!ASbLt#DCCT n=}y)<9)o-OMܓ
@R1E0A?õجn
v
lb|1D<fBUi^oEf)Wϙ0ajyvf|?2ַ\PIgM-Taʠ:03˯'OX4eZqY?S
*-ZuXWљ{gF@Ym {}#01 [hOZ5˦goҪNK'~L^2~_:ɘ4MO}\Gu+ƧB{|9{e:O][7bgZ](Q]zL/Qeyq>[I]5CCP吏j?WRҸ//Z*W"AEwab⋠ZW*Mt#ϥ#P ojg
\*ypC~ v%jnjV.0SEiS\7M|7IˠKO4^%O6/(w<\pW˥R߈ѻI~%"(#qI
/r}˓ƫRfA=+q